This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignee: Sanwa Kagaku Kenkyusho Co., Ltd.. Active years: 1996-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Nagoya, JP (1996)
- Aichi, JP (1996)
- Aichi-ken, JP (1998)
Company Filing History:
Years Active: 1996-1998
Title: Shigeaki Yoshina: Innovator in Pharmaceutical Composition
Introduction
Shigeaki Yoshina is a prominent inventor based in Nagoya, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that utilize biologically active peptides. With a total of 3 patents to his name, Yoshina's work has the potential to impact various therapeutic applications.
Latest Patents
Yoshina's latest patents include a pharmaceutical composition containing a fat emulsion with microspheres. This composition is designed to have its electric charge adjusted to a negative value, allowing for the effective adsorption of biologically active substances such as basic peptides and proteins. Additionally, he has developed a calcitonin analogue, which features a unique amino acid sequence that enhances its therapeutic potential.
Career Highlights
Yoshina is currently associated with Sanwa Kagaku Kenkyusho Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work focuses on creating compositions that improve the delivery and efficacy of biologically active substances. His contributions have been recognized within the industry, showcasing his expertise and commitment to advancing pharmaceutical science.
Collaborations
Yoshina has collaborated with notable colleagues, including Hitoshi Noda and Tsutomu Ishida. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the development of innovative solutions in the pharmaceutical field.
Conclusion
Shigeaki Yoshina is a distinguished inventor whose work in pharmaceutical compositions demonstrates his dedication to innovation. His patents reflect a commitment to improving therapeutic options through advanced scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile